Skip to main content
Clinical Trials/NCT02716025
NCT02716025CompletedNot Applicable

Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection

Ain Shams University0 sites75 target enrollmentStarted: October 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
75
Primary Endpoint
Detection of positive upper GIT endoscopic findings

Study Overview

Brief Summary

Fifty consecutive patients with symptoms suggestive of peptic ulcer disease were included. All underwent complete clinical evaluation, laboratory investigations, upper gastrointestinal endoscopy and rapid urease test. Measurement of serum zinc level was done for all the included patients in addition to twenty five age and sex matched healthy control subjects.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Symptoms suggestive of peptic ulcer disease like epigastric pain, dyspepsia, heartburn

Exclusion Criteria

  • Patients who received zinc supplementation, proton pump inhibitors (PPI), non-steroidal anti-inflammatory drugs (NSAIDs)
  • Those presented with hematemesis or melena
  • Those with chronic liver disease, renal failure, malabsorption or previous gastric surgery

Outcomes

Primary Outcomes

Detection of positive upper GIT endoscopic findings

Time Frame: upon endoscopy

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sara Abdelhakam

Assistant Professor

Ain Shams University

Similar Trials

Serum Zinc, Peptic Ulcer Disease and H.... | Clinical Trial